相关实验视频

Updated: Jan 12, 2026

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread

Published on: July 7, 2023

转移性乳腺癌中的单细胞转录组学:绘制瘤演变和治疗耐药性的地图

Xu Han¹, Xin Li¹, Ling Bai²

¹Breast Center, Baotou City Cancer Hospital, Baotou, Inner Mongolia, China.

Frontiers in genetics

|November 7, 2025

概括

单细胞转录组学 (SCT) 通过详细介绍瘤进化和抵抗机制,彻底改变了转移性乳腺癌 (MBC) 研究. 这项技术为罕见细胞群体和瘤微环境提供了洞察力,为精确瘤学铺平了道路.

科学领域:

在瘤学瘤学.
基因组学就是基因组学.
分子生物学分子生物学

背景情况:

转移性乳腺癌 (MBC) 是癌症死亡的主要原因.
瘤异质性和治疗耐药性是MBC的关键挑战.
传统的方法难以捕获MBC中的关键细胞细节.

研究的目的:

审查单细胞转录组学 (SCT) 如何推进MBC研究.
突出SCT在理解瘤进化和耐药性的作用.
探索SCT在MBC中的翻译潜力.

主要方法:

对MBC进行单细胞转录组学 (SCT) 分析.
绘制瘤进化和细胞异质性的地图.
研究瘤微环境相互作用.

主要成果:

SCT揭示了MBC中的克隆和空间异质性.
识别癌症干细胞类细胞和上皮细胞-介质细胞过渡状态.
揭示了治疗耐药性和免疫逃避机制.

结论:

SCT提供了对MBC复杂性的高分辨率洞察力.
与其他omics平台的集成增强了对MBC生态系统的理解.
在MBC中,SCT对生物标志物发现和精确治疗具有重大前景.

关键词:

这就是ScRNA-seqq.转移性乳腺癌转移性乳腺癌精确瘤学精确瘤学治疗性抗药性是一种治疗性抗药性.瘤异质性的异质性

更多相关视频

Labeling of Breast Cancer Patient-derived Xenografts with Traceable Reporters for Tumor Growth and Metastasis Studies

Labeling of Breast Cancer Patient-derived Xenografts with Traceable Reporters for Tumor Growth and Metastasis Studies

Published on: November 30, 2016

Discovery of Metastatic Regulators using a Rapid and Quantitative Intravital Chick Chorioallantoic Membrane Model

Discovery of Metastatic Regulators using a Rapid and Quantitative Intravital Chick Chorioallantoic Membrane Model

Published on: February 3, 2021

相关概念视频

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...